Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells

Medicine and Dentistry

• Inflammatory Mediator 100%
• Mitogen-Activated Protein Kinase 100%
• Mast Cell 100%
• Immediate Type Hypersensitivity 100%
• Messenger RNA 50%
• Cytokine 50%
• Tumor Necrosis Factor 50%
• Phosphorylation 50%
• Mediator 50%
• Phosphotransferase 50%
• A23187 50%
• Interleukin 4 50%
• Cyclooxygenase 2 50%
• Amino Terminal Sequence 50%
• Isotopes of Calcium 50%
• Secretion (Process) 50%
• Calcium Ion 50%
• Chemokine 50%
• Interleukin 13 50%
• Prostaglandin E2 50%
• Histamine 50%
• Histamine Release 50%
• Phorbol 13 Acetate 12 Myristate 50%
• Mast Cell Leukemia 50%
• Beta N Acetylhexosaminidase 50%
• Degranulation 50%
• Arachidonate 5 Lipoxygenase 50%
• Therapeutic Procedure 50%
• Cells 50%
• Aptitude 50%
• Leukotriene C4 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Mitogen Activated Protein Kinase 100%
• Antiallergic 100%
• Immediate Type Hypersensitivity 100%
• Phosphotransferase 50%
• Messenger RNA 50%
• Cyclooxygenase 2 50%
• Cytokine 50%
• Prostaglandin E2 50%
• Chemokine 50%
• Tumor Necrosis Factor 50%
• 12-O-Tetradecanoylphorbol-13-Acetate 50%
• Calcimycin 50%
• Calcium Ion 50%
• Interleukin 4 50%
• Interleukin 13 50%
• Histamine 50%
• Arachidonate 5 Lipoxygenase 50%
• Mast Cell Leukemia 50%
• Beta N Acetylhexosaminidase 50%
• Nutmeg 50%
• Leukotriene C4 50%
• Calcium 50%
• Rat 50%